Eurofins CDMO has expanded its existing drug product operation capabilities with the early 2020 completion of its new drug product development and cGMP manufacturing facility, located in Mississauga, Canada.
In 2017, Eurofins Scientific acquired Alphora Research Inc. to support Eurofins’ drug development platform. Starting in July, the commercial brand for Eurofins Alphora will be ...